Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma

David B. Solit, Iman Osman, David Polsky, Katherine S. Panageas, Adil Daud, James S. Goydos, Jerrold Teitcher, Jedd D. Wolchok, F. Joseph Germino, Susan E. Krown, Daniel Coit, Neal Rosen, Paul B. Chapman

Research output: Contribution to journalArticlepeer-review

172 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science